ClinicalTrials.gov record
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
ClinicalTrials.gov ID: NCT01499082
Public ClinicalTrials.gov record NCT01499082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both Plus Mealtime Insulin in Patients With Type 2 Diabetes Mellitus With a 6-month Safety Extension Period
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: * To compare the efficacy of insulin glargine new formulation and Lantus in terms of change in HbA1c from baseline to endpoint (scheduled month 6) in adult participants with type 2 diabetes mellitus Secondary Objectives: * To compare the efficacy of insulin glargine new formulation and Lantus in terms of occurrence of nocturnal Hypoglycemia
Study identification
- NCT ID
- NCT01499082
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 807 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Type not available)
- Primary completion
- Jan 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Mar 25, 2022
2011 – 2013
United States locations
- U.S. sites
- 95
- U.S. states
- 31
- U.S. cities
- 81
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840156 | Chandler | Arizona | 85224 | — |
| Investigational Site Number 840102 | Glendale | Arizona | 85306 | — |
| Investigational Site Number 840071 | Phoenix | Arizona | 85028 | — |
| Investigational Site Number 840121 | Sun City | Arizona | 85351 | — |
| Investigational Site Number 840070 | Tempe | Arizona | 85282 | — |
| Investigational Site Number 840016 | Hot Springs | Arkansas | 71913 | — |
| Investigational Site Number 840015 | Little Rock | Arkansas | 72205 | — |
| Investigational Site Number 840124 | Little Rock | Arkansas | 72205 | — |
| Investigational Site Number 840032 | Searcy | Arkansas | 72143 | — |
| Investigational Site Number 840076 | Anaheim | California | 92801 | — |
| Investigational Site Number 840133 | Encino | California | 91436 | — |
| Investigational Site Number 840062 | Greenbrae | California | 94904 | — |
| Investigational Site Number 840057 | Huntington Beach | California | 92648 | — |
| Investigational Site Number 840059 | La Jolla | California | 92037 | — |
| Investigational Site Number 840004 | La Mesa | California | 91942 | — |
| Investigational Site Number 840099 | Mission Hills | California | 91345 | — |
| Investigational Site Number 840107 | Palm Springs | California | 92262 | — |
| Investigational Site Number 840005 | San Diego | California | 92161 | — |
| Investigational Site Number 840013 | Tustin | California | 92780 | — |
| Investigational Site Number 840002 | Walnut Creek | California | 94598 | — |
| Investigational Site Number 840114 | Colorado Springs | Colorado | 80906 | — |
| Investigational Site Number 840136 | Colorado Springs | Colorado | 80910 | — |
| Investigational Site Number 840092 | Longmont | Colorado | 80501 | — |
| Investigational Site Number 840049 | Daytona Beach | Florida | 32117 | — |
| Investigational Site Number 840050 | Hollywood | Florida | 33021 | — |
| Investigational Site Number 840086 | Jacksonville | Florida | 32204 | — |
| Investigational Site Number 840011 | Jacksonville | Florida | 32216 | — |
| Investigational Site Number 840009 | Jacksonville | Florida | 32258 | — |
| Investigational Site Number 840023 | New Port Richey | Florida | 34652 | — |
| Investigational Site Number 840012 | Ocoee | Florida | 34761 | — |
| Investigational Site Number 840148 | Palm Harbor | Florida | 34684 | — |
| Investigational Site Number 840055 | Lawrenceville | Georgia | 30045 | — |
| Investigational Site Number 840052 | Idaho Falls | Idaho | 83404 | — |
| Investigational Site Number 840117 | Nampa | Idaho | 83686 | — |
| Investigational Site Number 840020 | McHenry | Illinois | 60050 | — |
| Investigational Site Number 840019 | Springfield | Illinois | 62704 | — |
| Investigational Site Number 840078 | Avon | Indiana | 46123 | — |
| Investigational Site Number 840089 | Avon | Indiana | 46123 | — |
| Investigational Site Number 840097 | Avon | Indiana | 46123 | — |
| Investigational Site Number 840098 | Avon | Indiana | 46123 | — |
| Investigational Site Number 840100 | Avon | Indiana | 46123 | — |
| Investigational Site Number 840127 | Vincennes | Indiana | 47591 | — |
| Investigational Site Number 840116 | Des Moines | Iowa | 50314 | — |
| Investigational Site Number 840003 | Wichita | Kansas | 67211 | — |
| Investigational Site Number 840080 | Lexington | Kentucky | 40504 | — |
| Investigational Site Number 840042 | Paducah | Kentucky | 42003 | — |
| Investigational Site Number 840036 | Baltimore | Maryland | 21237 | — |
| Investigational Site Number 840155 | Baltimore | Maryland | 21237 | — |
| Investigational Site Number 840034 | Rockville | Maryland | 20852 | — |
| Investigational Site Number 840065 | Ann Arbor | Michigan | 48106 | — |
| Investigational Site Number 840066 | Dearborn | Michigan | 48124 | — |
| Investigational Site Number 840103 | Flint | Michigan | 48504 | — |
| Investigational Site Number 840126 | Kalamazoo | Michigan | 49048 | — |
| Investigational Site Number 840022 | Southfield | Michigan | 48034 | — |
| Investigational Site Number 840143 | Chaska | Minnesota | 55318 | — |
| Investigational Site Number 840068 | Eagan | Minnesota | 55122 | — |
| Investigational Site Number 840085 | Minneapolis | Minnesota | 55416 | — |
| Investigational Site Number 840053 | Kalispell | Montana | 59901 | — |
| Investigational Site Number 840090 | Fremont | Nebraska | 68025 | — |
| Investigational Site Number 840091 | Omaha | Nebraska | 68130 | — |
| Investigational Site Number 840058 | Las Vegas | Nevada | 89148 | — |
| Investigational Site Number 840043 | Brick | New Jersey | 08274 | — |
| Investigational Site Number 840152 | Toms River | New Jersey | 08721 | — |
| Investigational Site Number 840146 | Asheville | North Carolina | 28801 | — |
| Investigational Site Number 840145 | Hickory | North Carolina | 28601 | — |
| Investigational Site Number 840045 | Wilmington | North Carolina | 28401 | — |
| Investigational Site Number 840067 | Fargo | North Dakota | 58103 | — |
| Investigational Site Number 840008 | Cincinnati | Ohio | 45236 | — |
| Investigational Site Number 840106 | Columbus | Ohio | 43213 | — |
| Investigational Site Number 840123 | Dayton | Ohio | 45439 | — |
| Investigational Site Number 840119 | Maumee | Ohio | 43537 | — |
| Investigational Site Number 840122 | Mentor | Ohio | 44060 | — |
| Investigational Site Number 840083 | Medford | Oregon | 97504 | — |
| Investigational Site Number 840084 | Portland | Oregon | 97239-3098 | — |
| Investigational Site Number 840007 | Uniontown | Pennsylvania | 15401 | — |
| Investigational Site Number 840079 | Greer | South Carolina | 29651 | — |
| Investigational Site Number 840048 | Rapid City | South Dakota | 57701 | — |
| Investigational Site Number 840039 | Chattanooga | Tennessee | 37404 | — |
| Investigational Site Number 840159 | Knoxville | Tennessee | 37912 | — |
| Investigational Site Number 840021 | Austin | Texas | 78731 | — |
| Investigational Site Number 840129 | Austin | Texas | 78731 | — |
| Investigational Site Number 840081 | Austin | Texas | 78758 | — |
| Investigational Site Number 840001 | Dallas | Texas | 75230 | — |
| Investigational Site Number 840047 | Dallas | Texas | 75246 | — |
| Investigational Site Number 840082 | Houston | Texas | 77096 | — |
| Investigational Site Number 840120 | Hurst | Texas | 76054 | — |
| Investigational Site Number 840010 | Draper | Utah | 84020 | — |
| Investigational Site Number 840060 | Ogden | Utah | 84403 | — |
| Investigational Site Number 840035 | Chesapeake | Virginia | 23321 | — |
| Investigational Site Number 840074 | Norfolk | Virginia | 23502 | — |
| Investigational Site Number 840112 | Norfolk | Virginia | 23507 | — |
| Investigational Site Number 840041 | Norfolk | Virginia | 23510 | — |
| Investigational Site Number 840104 | Richmond | Virginia | 23235 | — |
| Investigational Site Number 840075 | Williamsburg | Virginia | 23185 | — |
| Investigational Site Number 840018 | Milwaukee | Wisconsin | 53209-0996 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 98 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01499082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2022 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01499082 live on ClinicalTrials.gov.